These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12620284)

  • 1. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome.
    Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
    Neurochem Int; 2003 Jul; 43(2):155-64. PubMed ID: 12620284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
    Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
    Pharmacopsychiatry; 2004 Mar; 37(2):57-62. PubMed ID: 15048612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome.
    Nisijima K; Yoshino T; Yui K; Katoh S
    Brain Res; 2001 Jan; 890(1):23-31. PubMed ID: 11164765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone counteracts lethality in an animal model of the serotonin syndrome.
    Nisijima K; Yoshino T; Ishiguro T
    Psychopharmacology (Berl); 2000 May; 150(1):9-14. PubMed ID: 10867971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.
    Shioda K; Nisijima K; Kasai M; Yoshino T; Kato S
    Neurosci Lett; 2012 Oct; 528(1):22-6. PubMed ID: 22985508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome.
    Shioda K; Nisijima K; Yoshino T; Kato S
    Neurosci Lett; 2010 Oct; 482(3):216-9. PubMed ID: 20655983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT2A receptors in the serotonin (5-HT) syndrome caused by excessive 5-HT efflux in rat brain.
    Krishnamoorthy S; Ma Z; Zhang G; Wei J; Auerbach SB; Tao R
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):830-41. PubMed ID: 20456331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.
    Zhang G; Krishnamoorthy S; Ma Z; Vukovich NP; Huang X; Tao R
    Eur J Pharmacol; 2009 Aug; 615(1-3):66-75. PubMed ID: 19464285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.
    Colado MI; O'Shea E; Esteban B; Granados R; Green AR
    Neuropharmacology; 1999 Feb; 38(2):307-14. PubMed ID: 10218873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.
    Shioda K; Nisijima K; Yoshino T; Kato S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):633-40. PubMed ID: 15276688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.
    Ma Z; Zhang G; Jenney C; Krishnamoorthy S; Tao R
    Eur J Pharmacol; 2008 Jul; 588(2-3):198-206. PubMed ID: 18499101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole.
    Green AR; De Souza RJ; Williams JL; Murray TK; Cross AJ
    Neuropharmacology; 1992 Apr; 31(4):315-21. PubMed ID: 1381816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regionally specific effects of diazepam on brain serotonin metabolism in rats: sustained effects following repeated administration.
    Haleem DJ; Batool F
    Life Sci; 1996; 59(15):PL239-46. PubMed ID: 8845014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-induced neurodegeneration in rat brain.
    Colado MI; O'Shea E; Esteban B; Green AR
    Psychopharmacology (Berl); 2001 Aug; 157(1):82-8. PubMed ID: 11512047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists.
    MacGregor DG; Graham DI; Stone TW
    Exp Neurol; 1997 Nov; 148(1):110-23. PubMed ID: 9398454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is chlormethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study.
    Thaminy S; Reymann JM; Heresbach N; Allain H; Lechat P; Bentué-Ferrer D
    Pharmacol Biochem Behav; 1997 Apr; 56(4):737-45. PubMed ID: 9130301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.